Recurrent macular edema secondary to branch retinal vein occlusion
Conditions
Interventions
Subthreshold grid laser treatment
intravitreal bevacizumab injections
Sponsors
Department of Ophthalmology, University Vita-Salute, Scientific Institute San Raffaele
Eligibility
Sex/Gender
All
Inclusion criteria
Inclusion criteria: 1. patients affected by macular edema secondary to BRVO already undergone conventional grid laser photocoagulation 2. best corrected visual acuity (BCVA) between 20/400 and of 20/40 3. Central thickness greater than 250 microns on OCT
Exclusion criteria
Exclusion criteria: 1. detection of retinal capillary non-perfusion more than 5 disc diameter on fluorescein angiography coexistence of any other chorioretinal disease 2. presence of cataract or any other ocular conditions able to confound the results 3. uncontrolled systemic hypertension 4. peripheral vascular disease and history of thromboembolism, ischemic heart disease or stroke.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| The reduction in the mean central retinal thickness evaluate on optical coherence tomography scan. | — |
Secondary
| Measure | Time frame |
|---|---|
| The mean best-corrected visual acuity changes over the follow-up and the proportion of eyes that gained at least 15 letters (approximately 3 lines) at the 12-month examination. | — |
Countries
Europe
Contacts
Public ContactProf. Francesco Bandello
University Vita-Salute, Scientific Institute San Raffaele Department of Ophthalmology
Outcome results
None listed